ArticleKidney international reports2025

PHYOX3: Nedosiran Long-Term Safety and Efficacy in Patients With Primary Hyperoxaluria Type 1.

John C Lieske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.